Lokale Ablationsverfahren als Ergänzung der Therapie maligner Leberläsionen

Zusammenfassung

Bösartige Neubildungen in der Leber stellen in der gastroenterologisch-onkologischen Praxis eines der häufigsten und schwierigsten Probleme dar. Klinisch unterscheidet man zwischen primären, d. h. von Hepatozyten und Gallenwegen selbst ausgehenden Tumoren (hepatozelluläres Karzinom HCC, Cholangiokarzinom CC) und sekundären Läsionen der Leber, die Absiedlungen leberfremder Tumoren (Metastasen) darstellen und aufgrund ihrer unterschiedlichen Biologie verschiedene therapeutische Strategien erfordern. Das Prinzip, Tumore der Leber zu entfernen, hat sich jedoch sowohl bei primären als auch bei sekundären Läsionen durchgesetzt. Für viele Patienten mit primären oder sekundären Lebertumoren ist technisch oder aufgrund der Begleitmorbidität eine chirurgische Resektion nicht möglich. Das hat zur Entwicklung minimalinvasiver Ablationsverfahren geführt. Perkutane Alkohol- und Essigsäureinjektionen, Radiofrequenz-, Mikrowellen- oder Laserablationen ergänzen das Spektrum der therapeutischen Möglichkeiten und eröffnen die Möglichkeit der Tumorentfernung auch für Patienten, die technisch oder aufgrund ihrer Begleiterkrankungen nicht operiert werden können.

Abstract

Malignant lesions of the liver are among the most frequent and difficult problems in clinical practice. Liver tumors can be classified as primary (hepatocellular carcinoma HCC, cholangiocarcinoma CC) and secondary liver lesions (metastasis). The therapeutic principle of resecting liver tumours, applies to both types of liver lesions. Unfortunately many patients with primary and secondary liver lesions are inoperable because of technical difficulties or comorbidity. This stimulated the development of percutaneous ablation methods. These procedures allow to destroy tumors percutaneously with alcohol, acetic acid, radiofrequency, microwaves or laser. Potential applications and limitations of the methods are discussed.

Lokale Ablation - PEI - RFTA - PAI - LITT - Mikrowellenkoagulation

Local ablation - PEI - PAI - RFTA - microwave coagulation - LITT

Literatur

• 1 Alberts S R, Donohue J H, Mahoney M R. Liver resection after 5-FU, leucovorin and oxaliplatin for patients with metastatic colorectal cancer limited to the liver: A North Central Cancer Treatment (NCCTG) phase II study.  Proc Am Soc Clin Oncol. 2003;  22 263a, A1053
• 2 Allgaier H P, Galandi D, Olschewski M. et al . Dtsch Ärzteblatt. 2003;  100 A2666-A2687
• 3 Arii S, Yamaoka Y, Futagawa S. et al . Results of surgical and nonsurgical treatment for small sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan.  Hepatology. 2000;  32 1224
• 4 Bismuth H, Adam R, Levi F. et al . Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.  Ann Surg. 1996;  224 509-20 , discussion 520-522
• 5 Bonatti H, Bodner G, Obrist P. et al . Skin implant metastasis after percutaneous radiofrequency therapy of liver metastasis of a colorectal carcinoma.  Am Surg. 2003;  69 763-765
• 6 Castells A, Bruix J, Bru C. et al . Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.  Hepatology. 1993;  18 1121-1126
• 7 Dizon D S, Kemeny N E. Intrahepatic arterial infusion of chemotherapy: clinical results.  Seminar Oncol. 2002;  20 126-135
• 8 Elias D, De Baere T, Smayra T. et al . Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.  Br J Surg. 2002;  89 752-756
• 9 Falcone A, Masi G, Allegrini G. et al . Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil and leucovorin: a pilot study in patients with metastatic colorectal cancer.  J Clin Oncol. 2002;  20 4006-4014
• 10 Giacchetti S, Itzhaki M, Gruia G. et al . Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.  Ann Oncol. 1999;  10 663-669
• 11 Huo T, Huang Y H, Wu J C. et al . Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.  Scand J Gastroenterol. 2003;  38 770-778
• 12 , http://www.eortc.be
• 13 Kemeny N, Niedzwiecki D, Shurgot B. et al . Prognostic variables in patients with hepatic metastases form colorectal cancer. Importance of medical assessment of liver involvement.  Cancer. 1989;  63 742-747
• 14 Kotoh K, Sakai H, Sakamoto S. et al . The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.  Am J Gastroenterol. 1994;  89 194-198
• 15 Lencioni R A, Allgaier H P, Cloni D. et al . Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection.  Radiology. 2003;  228 235-240
• 16 Liang H L, Yang C F, Pan H B. et al . Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment.  Radiology. 2000;  214 769-774
• 17 Livraghi T, Solbiati L, Meloni M F. et al . Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study.  Radiology. 2003;  226 441-451
• 18 Livraghi T, Goldberg S N, Lazzaroni S. et al . Small hepatocellular carcinoma: Treatment with Radiofrequency Ablation versus ethanol injection.  Radiology. 1999;  210 656-661
• 19 Livraghi T, Goldberg S, Solbiati T. et al . Percutaneous radiofrequency ablation of liver metastasis from breast cancer. Initial experience with 24 patients.  Radiology. 2001;  220 145-149
• 20 Livraghi T, Solbiati L, Meloni F. et al . Percutaneous Radiofrequency Ablation of liver metastases in potential candidates for resection.  Radiology. 2003;  97 3027-3035
• 21 Livraghi T, Lazzaroni S, Pellicano S. et al . Percutaneous ethanol injection of hepatic tumors: single session therapy with general anethesia.  Am J Roentgenol. 1993;  161 1065-1069
• 22 Llovet. et al . Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.  Hepatology. 2001;  33 1124-1129
• 23 Llovet. et al . Chemoembolisation improved survival of stringently selected patients with unresectable heaptocellular cracinoma.  Lancet. 2002;  359 1734-1739
• 24 Llovet J M, Beaugrand M. Hepatocellular carcinoma: present status and future prospects.  Journal of Hepatology. 2003;  38 S136-S149
• 25 Lo C M, Ngan H, Tso W K. et al . Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma.  Hepatology. 2002;  35 1164-1171
• 26 Malafosse R, Penna C, Sa C unha A. et al . Surgical management of hepatic metastases from colorectal maignancies.  Ann Oncol. 2001;  12 887-894
• 27 Nagasue N, Kohno H, Tachibana M. et al . Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte Class B and C cirrhosis.  Ann Surg. 1999;  229 84-90
• 28 Nordlinger B, Guigeuet M, Vaillant J C. et al . Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection based on 1568 patients. Association Française de Chirurgie.  Cancer. 1996;  77 1254-1262
• 29 Oshowo A, Gillams A, Harrison E. et al . Resection of radiofrequency ablation for solitary colorectal liver metastases.  Br J Surg. 2002;  89 12-14
• 30 Parikh A A, Curley S A, Fornage B D. et al . Radiofrequency ablation of hepatic metastases.  Seminar Oncol. 2002;  29 168-182
• 31 Ruers T J, Joosten J, Jagher G J. et al . Long-term results of treating hepatic colorectal metastases with cryosurgery.  Br J Surg. 2001;  88 844-849
• 32 Rossi S, Garbagnati F, Lencioni R. et al . Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumour blood supply.  Radiology. 2000;  217 119-126
• 33 Shibata T, Jimuro Y, Yamamoto Y. et al . Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy.  Radiology. 2002;  223 331-337
• 34 Solbiati L, Goldberg S N, Ierace T. et al . Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients.  Radiology. 2001;  221 159-166
• 35 Souglakos J, Mavroudis D, Kakolyris S. et al . Triplet combination with irinotecan plus oxaliplatin plux continuous-infusion fluorouracil and leucvorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.  J Clin Oncol. 2002;  20 2651-2657
• 36 Vogl T J, Mack M G, Straub R. et al . Interventionelle MR-gesteuerte laserinduzierte Thermotherapie bei onkologischen Fragestellungen.  Radiologe. 1999;  39 764-771
• 37 Wietzke-Braun P, Ritzel D, Nolte W. et al . Ultrasound-guided laser intestitial thermotherapy for treatment of non-resectable primary and secondary liver tumours - a feasibility study.  Ultraschall in Med.. 2003;  24 107-112
• 38 Yamamoto J, Okada S, Shimada K. et al . Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.  Hepatology. 2001;  34 707-713
• 39 Yan D B, Clingan P, Morris D L. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?.  Cancer. 2003;  98 320-330
• 40 The C ancer of the Liver Italian Program investigators. Prospective Validation of the CLIP score: A new prognostic System for patients with cirrhosis and hepatocellular carcinoma.  Hepatology. 2000;  31 840-845